Long-term follow-up for adults with atrophic scars treated with TRTP-101
Long-Term Follow-up of Adult With Atrophic Scars Treated With TRTP-101 in Study CIC101-01
CellinCells · NCT06435884
This study is checking how well TRTP-101 works and if it's safe for adults with atrophic scars over five years after their initial treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | CellinCells (industry) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06435884 on ClinicalTrials.gov |
What this trial studies
This study is a long-term observational follow-up of adults who received TRTP-101 for atrophic scars in a previous clinical trial. It aims to evaluate the long-term safety and efficacy of the treatment over a period of five years. Participants will be monitored for any serious adverse events that may arise following their initial treatment. The study focuses on gathering comprehensive data to understand the lasting effects of TRTP-101 on scar management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who previously participated in the CIC101-01 clinical trial and received TRTP-101.
Not a fit: Patients who did not receive TRTP-101 in the prior clinical trial or are deemed unsuitable for long-term follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of TRTP-101 for treating atrophic scars.
How similar studies have performed: While this study focuses on long-term follow-up, similar studies evaluating the safety and efficacy of treatments for atrophic scars have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Received TRTP-101 in clinical trial CIC101-01 * Provided written informed consent to participate in this study Exclusion Criteria: * Judged to be unsuitable to participate in this long-term follow-up
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Principal investigator: JongHee Lee, MD — Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine
- Study coordinator: HyeJung Park, Director
- Email: hjpark@cellincells.com
- Phone: 82-70-4469-9115
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Atrophic Scar